MGRO — MustGrow Biologics Income Statement
0.000.00%
Last trade - 00:00
- CA$37.57m
- CA$32.44m
- CA$4.71m
- 70
- 18
- 10
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.013 | 0.006 | 4.71 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.47 | 3.26 | 3.02 | 5.69 | 5.52 |
Operating Profit | -1.47 | -3.26 | -3.01 | -5.69 | -0.805 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.52 | -3.31 | -3.06 | -5.57 | -0.677 |
Net Income After Taxes | -1.52 | -3.31 | -3.06 | -5.57 | -0.677 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.52 | -3.31 | -3.06 | -5.57 | -0.677 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.52 | -3.31 | -3.06 | -5.57 | -0.677 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.06 | -0.092 | -0.07 | -0.114 | -0.014 |